Metformin and Malignant Tumors: Not Over the Hill [Response to Letter]
Weiling Leng,1,* Juan Jiang,2,* Bing Chen,1 Qinan Wu3 1Endocrinology Department, The First Affiliated Hospital of the Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China; 2Endocrinology and Nephrology Department, Chongqing University Cancer Ho...
Guardado en:
Autores principales: | Leng W, Jiang J, Chen B, Wu Q |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d4b7314b6b44630ae57461f54d7ea3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metformin and Malignant Tumors: Not Over the Hill
por: Leng W, et al.
Publicado: (2021) -
Metformin and Malignant Tumors: Not Over the Hill: A Short Comment [Letter]
por: Rastmanesh R
Publicado: (2021) -
Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
por: Leng W, et al.
Publicado: (2021) -
An easily ignored factor for CAN-fine particulate exposure [Response to Letter]
por: Vasheghani M
Publicado: (2019) -
Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
por: Bruckbauer A, et al.
Publicado: (2013)